2024年四川省不同检测策略下人类免疫缺陷病毒抗体检测者重复检测情况分析

Analysis on repeated testing of HIV antibody tester under different testing strategies in Sichuan province, 2024

  • 摘要:
    目的 分析四川省不同检测策略下人类免疫缺陷病毒(HIV)抗体检测者的重复检测情况,为优化HIV 检测服务策略提供依据。
    方法 本研究通过四川省健康档案云平台收集2024年四川省所有HIV检测点开展的HIV抗体检测个案记录,采用SPSS 26软件进行数据整理和统计分析,对HIV抗体重复检测进行一般及分布情况的统计描述;对不同检测策略的HIV抗体重复检测率以及不同样本来源重复检测率进行χ2检验,并采用Bonferroni法校正检验水准进行两两比较;计算不同检测策略的重复检测间隔时间的中位数和四分位数,采用Kruskal Wallis秩和检验比较重复检测间隔时间差异。
    结果 2024年四川省共计33 395 867人接受了HIV抗体检测,全人群检测覆盖比例为39.91%,其中有10 449 020名HIV抗体检测者本年有过≥2次的HIV抗体检测,平均检测次数为2.73次,重复检测间隔时间的中位数为43 d,四分位数为14 d和110 d。 HIV抗体检测记录共计51 517 888人次,HIV抗体重复检测率为35.18%,男性重复检测率33.29%低于女性36.75%,<50岁重复检测率31.08%低于≥50岁38.04%。 不同地区重复检测率26.45% ~41.66%。 本研究将检测策略分为六类,不同HIV 检测策略的重复检测率由高到低依次为政策强制检测(88.06%)、临床诊疗相关医疗机构医务人员主动提供检测咨询 (PITC) ( 42.11 %)、自愿咨询检测(31.43 %)、基于社区以及社会网络动员的检测(30.05%)、全人群专项筛查(25.33%)、公共卫生服务相关PITC(23.94 %);重复检测间隔时间中位数最小为政策强制检测(14 d),其次为全人群专项筛查(27 d);PITC中重复检测率最高的样本来源为孕产期检查,为52.88%;其次为受血(制品)前检测,为48.46%,以及其他就诊者检测,为41.72%。
    结论 四川省的重复检测率反映了不同检测策略中在检测量增加的同时HIV抗体检测服务覆盖未检测的人群效率不同,也表明HIV抗体检测服务中的个体重复检测现象有一定的普遍性,提示在重复检测方面关注及优化的方向,需要根据不同人群及检测来源进一步探究有差异的HIV抗体筛查频率。

     

    Abstract:
    Objective To analyze the repetitive HIV tests under different HIV testing strategies in Sichuan province and provide evidence for the optimization of HIV testing service.
    Methods In this study, the HIV-antibody testing records of Sichuan province in 2024 were collected from the Sichuan health records cloud platform. SPSS 26 software was used for data cleaning and statistical analysis, and statistical description of the general and distribution situation of repeated tests for HIV antibodies was conducted. χ2 were performed of the repeated HIV-antibody testing rates by different testing strategies and by different sample sources, with pairwise comparisons adjusted using the Bonferroni method; The median and quartile of repeat testing interval for different HIV-antibody testing strategies were calculated, and the Kruskal Wallis rank sum test was used to compare the differences in repeat testing interval.
    Results In 2024, a total of 33 395 867 people in Sichuan Province underwent HIV-antibody testing, with a coverage rate of 39.91% for the entire population. Among them, 10 449 020 individuals had undergone two or more HIV-antibody tests. The average times of tests was 2.73, The median interval between repeated tests was 43 days, and the interquartiles were 14 days and 110 days. The total number of HIV-antibody tests conducted in Sichuan Province in 2024 reached 51 517 888 times, the repeat HIV-antibody testing rate was 35.18%, the repeat testing rate of male was 33.29% lower than that of female (36.75%), and the repeat testing rate of individuals below 50 years old was 31.08% lower than aged 50 and older 38.04%. In this study, the HIV testing strategies were divided into six categories. The repeat testing rates of different HIV testing strategies from high to low were: policy-mandatory testing(88.06%), PITC related to clinical diagnosis and treatment(42.11 %), voluntary counseling and testing(31.43%), community-based and social network mobilization testing(30.05%), population-specific screening(25.33%), and public health services-related PITC(23.94%); The median interval between repeated tests was the smallest for policy-mandated testing (14 days), followed by for special screening of the entire population (27 days). The sample source with the highest repetitive testing rate in PITC was pregnancy examination 52.88%. The second was testing before blood transfusion 48.46%, and testing by other clinical patients 41.72%.
    Conclusion The repeated testing rate in Sichuan Province reflects the varying efficiency of HIV-antibody testing services in covering untested populations as the testing volume increases among different testing strategies. The repetitive testing rate of HIV antibodies in Sichuan Province also reveals that the phenomenon of individual repetitive testing in HIV-antibody testing services is common, suggests the direction of attention and optimization in terms of repeated testing.It is necessary to further explore the different screening frequencies of HIV antibodies based on different populations and testing sources.

     

/

返回文章
返回